{"contentid": 488402, "importid": NaN, "name": "J&J results show significant growth in sales and earnings", "introduction": "US healthcare giant Johnson & Johnson has announced results for the first quarter of 2021.", "content": "<p>US healthcare giant Johnson &amp; Johnson (NYSE: JNJ) has announced results for the first quarter of 2021.</p>\n<p>Reported sales hit $22.32 billion, a 7.9% climb on the figure for the first quarter of 2020, while adjusted earnings per share (EPS) increased 12.6%to $2.59, beating analysts&rsquo; expectations according to Refinitiv.</p>\n<p>In the Pharmaceuticals division, sales rose by 9.6% to $12.2 billion, including $100 million from sales of J&amp;J&rsquo;s COVID-19 vaccine.</p>\n<p>J&amp;J has tightened its estimate for reported sales for 2021 as a whole by $0.1 million at each end of the range. The adjusted EPS estimate has also been tightened, with a rise of 17.3% to 19.2% now projected.</p>\n<p>Shares in J&amp;J were marginally lower ahead of the opening of markets on Tuesday.</p>\n<p>Alex Gorsky, chairman and chief executive, said: &ldquo;J&amp;J delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices.</p>\n<p>&ldquo;The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000 employees of J&amp;J.&rdquo;</p>\n<h2>Selected quarterly product sales</h2>\n<p>Stelara (ustekinumab): $2.15 billion, up 18%</p>\n<p>Darzalex (daratumumab): $1.37 billion, up 46%</p>\n<p>Imbruvica (ibrutinib): $1.13 billion, up 9%</p>\n<p>Remicade (infliximab): $777 million, down 22%</p>\n<p>Simponi/Simponi Aria (golimumab): $562 million, up 6%</p>", "date": "2021-04-20 13:24:00", "meta_title": NaN, "meta_keywords": "sales, results, Johnson, quarter, billion, earnings, significant, growth, million, show, healthcare, giant, announced, reported, tightened, NYSE, adjusted", "meta_description": "US healthcare giant Johnson & Johnson has announced results for the first quarter of 2021.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-20 13:23:23", "updated": "2021-04-20 14:01:16", "access": NaN, "url": "https://www.thepharmaletter.com/article/j-j-results-show-significant-growth-in-sales-and-earnings", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "jnjn_flickr_big.png", "image2id": "jnjn_flickr_small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Anti-Arthritics/Rheumatics, Hematology, Immunologicals, Inflammatory diseases, Oncology", "topic_tag": "Financial, Management", "geography_tag": "USA", "company_tag": "Johnson & Johnson", "drug_tag": "Darzalex, Imbruvica, Remicade, Simponi, Stelara", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-20 13:24:00"}